International Journal of Medical Laboratory Research (IJMLR)

IMPACT OF POINT-OF-CARE TESTING ON CLINICAL OUTCOMES IN PEDIATRIC ACUTE ILLNESSES

​

J Subha Sri, B Bharathi, Deepa C. Philip

​

ABSTRACT: This review evaluates the utility of C-reactive protein (CRP) as an inflammatory biomarker in pediatric respiratory and bacterial infections, focusing on its application in primary and ambulatory care settings. Utilizing point-of-care (PoC) CRP testing, the research aims to enhance diagnostic accuracy and inform clinical decisions. Elevated CRP levels signify acute inflammation, common in diseases such as asthma and allergic rhinitis, where immune responses are complex. High-sensitivity CRP assays may help grade inflammation severity. The study, which employed the Affinion CRP test for rapid results, highlights CRP's role in identifying higher-risk cases but underscores its limitations in excluding severe infections without supplementary clinical data. Comparing CRP to procalcitonin revealed that the latter often provides superior sensitivity and specificity for detecting invasive bacterial infections. The findings advocate for incorporating CRP into structured diagnostic protocols, which could optimize pediatric care by reducing unnecessary antibiotic use. Standardized cutoff values and multimodal biomarker strategies are recommended for refining diagnostic approaches.

​

KEYWORDS: C-reactive protein, allergic rhinitis, point -of-care.

​

REFERENCES:​​

1. Kolbas V, Lokar R, Stanic M, Krznaric-Sucic Z. Prevalencija astme u djece školske dobi na području grada Zagreba. Arhiv Zaštite Majke i Djeteta. 1979; 23:351-63.

2. Aberle N, Reiner-Banovac Z. Epidemiološko ispitivanje astme u djece. Pediatria Croatica. 1998; 42:914.

3. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association. 2001; 286:327-34.

4. Xu Y, Whitmer K. American Journal of Nursing. 2006;106(8):66-72.

5. National Heart, Lung, and Blood Institute. Asthma management and prevention: a practical guide – 1996. NIH Publication No.96-3659 B.

6. National Heart, Lung, and Blood Institute. Global strategy for asthma management and prevention, 2002. NIH Publication No. 02-3659.

7. Moran A. University of Minnesota Health Care Pediatric Department, MMC 404, 516 Delaware St. SE, Minneapolis, MN 55455.

8. Pepys MB, Baltz MC. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Advances in Immunology. 1983; 34:141-212.

9. Silverman LM, Christenson RN. Amino acid and proteins. In: Burtis CA, Ashwood ER, eds. Tietz Fundamentals of Clinical Chemistry. 4th ed. Philadelphia: WB Saunders Company; 1996. p. 240-82.

10. Whicher J. C-reactive protein (CRP). In: Thomas L, ed. Clinical Laboratory Diagnostics. 1st ed. Frankfurt/Main: TH-Books; 1998. p. 700-6.

11. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107:363-9.

12. Takemura M, Matsumoto H, Niimi A, High sensitivity C-reactive protein in asthma. European Respiratory Journal. 2006; 27:908-11.

13. Lemiengre MB, Verbakel JY, Colman R, reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions. British Journal of General Practice. 2018;68(668): e204–e210.

14. Lemiengre MB, Verbakel JY, De Burghgraeve T, optimizing antibiotic prescribing for acutely ill children in primary care (ERNIE2 study protocol, part B): a cluster randomized, factorial controlled trial evaluating the effect of a point-of-care C-reactive protein test and a brief intervention combined with written safety net advice. BMC Pediatrics. 2014; 14:246.

15. Verbakel JY, Lemiengre MB, De Burghgraeve T, diagnosing serious infections in acutely ill children in ambulatory care (ERNIE 2 study protocol part A): diagnostic accuracy of a clinical decision tree and added value of a point-of-care C-reactive protein test and oxygen saturation. BMC Pediatrics. 2014; 14:207.

16. Gómez B, Mintegi S, Bressan S, Validation of the “step-by-step” approach in the management of young febrile infants. Pediatrics. 2016;138: e20154381.

17. Pantell RH, Roberts KB, Adams WG, Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148: e2021052228.

18. Kuppermann N, Dayan PS, Levine DA, A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatrics. 2019; 173:342–51.

19. Verbakel JY, Lemiengre MB, De Burghgraeve T, De Sutter A, Aertgeerts B, should all acutely ill children in primary care be tested with point-of-care CRP? A cluster randomised trial. BMC Medicine. 2016;14(1):131.

20. Verbakel JY, Aertgeerts B, Lemiengre M, De Sutter A, Bullens DMA, Buntinx F. Analytical accuracy and user-friendliness of the Afinion point-of-care CRP test. Journal of Clinical Pathology. 2014;67(1):83–6.

21. Van Den Bruel A, Jones C, Thompson M, Mant D. C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Archives of Disease in Childhood. 2016;101(4):382–5.

22. Cals JWL, Butler CC, Hopstaken RM, Effect of point-of-care testing for C-reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. British Medical Journal. 2009;338: b1374.

23. Huang Y, Chen R, Wu T, Association between point-of-care C-reactive protein testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. British Journal of General Practice. 2013;63: e787–94.

24. Schot MJC, Dekker ARJ, Giorgi WG, Point-of-care C-reactive protein to assist in primary care decisions for lower respiratory tract infections: a randomised controlled trial. British Journal of General Practice. 2018;68(676): e612–e620.

25. Cassidy CA, Kabugho L, Kibaba G, Comparison of commercially available, rapid, point-of-care C-reactive protein assays among children with febrile illness in southwestern Uganda. PLOS Global Public Health. 2024;4(1): e0002727.

26. Norman-Bruce, H., Umana, E., Mills, C., McFetridge, L., Mitchell, H., & Waterfield, T.
    Diagnostic Test Accuracy of Procalcitonin and C-Reactive Protein for Predicting Invasive and Serious Bacterial Infections in Young Febrile Infants: A Systematic Review and Meta-analysis
    The Lancet Child & Adolescent Health. 2024; 8(5), Pages 358-368.

27. Lorrot, M., Moulin, F., Coste, J., Ravilly, S., Guérin, S., Lebon, P., Lacombe, C., Raymond, J., Bohuon, C., & Gendrel, D. Procalcitonin in Pediatric Emergencies: Comparison with C-Reactive Protein, Interleukin-6, and Interferon Alpha in the Differentiation Between Bacterial and Viral Infections.  Archives de Pédiatrie, 2014; 7(6), 611-616.

28. Yo, C. H., Hsieh, P. S., Lee, S. H., Wu, J. Y., Chang, S. S., Tasi, K. C., & Lee, C. C.
    Comparison of the Test Characteristics of Procalcitonin to C-Reactive Protein and Leukocytosis for the Detection of Serious Bacterial Infections in Children Presenting with Fever Without Source: A Systematic Review and Meta-analysis Annals of Emergency Medicine; 2012; 60(5), 591-600.e4.

29. Simhachalam, M., Vasundhara, A., Swetha, L., & Sudarsini, P. Comparative Study of Procalcitonin Versus C-Reactive Protein in the Diagnosis of Sepsis in Children Below 16 Years: A Single Centre Observational Study Pediatric Review: International Journal of Pediatric Research, 2017; 4(1), 25-30.